F35596a7-figure-01 (F35596a7 Figure 01)
Tadalafil Tablet
Product Images NDC 50090-7152
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-7152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
F35596a7-figure-02 (F35596a7 Figure 02)
This text mentions the parameters for measuring blood pressure in both standing and supine positions, including diastolic and systolic values. It also includes a note about measurement units and potentially a reference to time.*
F35596a7-figure-03 (F35596a7 Figure 03)
F35596a7-figure-04 (F35596a7 Figure 04)
F35596a7-figure-05 (F35596a7 Figure 05)
F35596a7-figure-06 (F35596a7 Figure 06)
This text provides information about the IPSS Total Score change from baseline in a study comparing Tadalafil tablets 5 mg versus placebo over a duration of treatment of 0, 4, 8, and 12 weeks. The data indicates a significant difference between the two groups at a significance level of p<0.001.*
F35596a7-figure-07 (F35596a7 Figure 07)
F35596a7-figure-08 (F35596a7 Figure 08)
F35596a7-figure-09 (F35596a7 Figure 09)
This is a study comparing Tadalafil tablets 5 mg to a placebo. The results indicate a statistically significant difference with a p-value less than 0.01. The graph shows the duration of treatment in weeks on the x-axis and an unspecified measure on the y-axis over time.*
Label Image (Lbl500907152)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
